Published online by Cambridge University Press: 18 July 2014
Current interest in the non-medical use of cocaine in Canada can be gauged by the attention this drug is getting in the various media. Not surprisingly, researchers have now entered the arena in the hope of answering some of the questions posed by this phenomenon. A similar trend occurred in regard to marijuana more than a decade ago when popular concern led to a federal commission that eventually recommended the repeal of the offence of cannabis possession. The wave of concern created considerable scholarly interest in Canada's approach to the control of narcotic drugs, including cannabis, which had been defined as narcotic for legal purposes. Much research followed on various fronts, from studies on the effects of cannabis on health to the social consequences of punishment.
Several studies have examined the origins of Canada's legislative response to narcotic drug use. A principal conclusion from these studies is that legislation became possible because of hostility toward minority groups associated with drug use, specifically, the Chinese who were known for their use of opium. In the present paper, however, we see that drug control grew as much out of a “cocaine scare” as out of concern with opium use. Moreover, cocaine attracted attention in part precisely because its use was not confined to despised minorities, but permeated society as a whole, affecting “young people as well as seniors,” “men and women,” those from “poorer classes,” those from “respectable families” and those “who should and do know better.”
1. Weber (1947) argued that culture gives meaning to orientation problems. He said that we study things that are relevant to us and the society in which we live. Parsons, T. (ed.), Henderson, A.M. and Parsons, T. (trans.), Max Weber: The Theory of Social and Economic Organization (New York: Oxford University Press, 1947)Google Scholar. In fact, the present paper is the second study the author has made of the history of cocaine use in Canada. In an earlier study, the phenomenon of cocaine use today was found to parallel the one that appeared a century ago. This finding was reported in Murray, G.F. and Erickson, P.G., “The Second Time Around: Old and New Cycles in the Definition of Cocaine as a Social Problem,” a Paper presented to the American Society of Criminology Annual Meeting, San Diego, California, November 13–17, 1985Google Scholar. A revised version of that paper is presented in chapter one of Erickson, P.G., Adlaf, E.M., Murray, G.F. and Smart, R.G., The Steel Drug: Cocaine in Perspective (Lexington: D.C. Heath and Company, 1987)Google Scholar.
2. Commission, LeDain, Commission of Inquiry into the Non-Medical Use of Drugs, ‘Cannabis’ (Ottawa: Information Canada, 1972)Google Scholar.
3. Boyd, N., “The Origins of Canadian Narcotics Legislation: The Process of Criminalization in Historical Context,” Dalhousie Law Journal 8 (1984), 102–136Google Scholar.
4. Fehr, K.O. and Kalant, H. (eds.), Cannabis and Health Hazards: Proceedings of an ARF/WHO Scientific Meeting on Adverse Health and Behavioral Consequences of Cannabis Use (Toronto: Addiction Research Foundation, 1983)Google Scholar; See also Kalant, O.J., Fehr, K.O., Arras, D. and Anglin, L., Cannabis Health Risks: A Comprehensive Annotated Bibliography (1844–1982) (Toronto: Addiction Research Foundation, 1983)Google Scholar.
5. Erickson, P.G., Cannabis Criminals: The Social Effects of Punishment on Drug Users (Toronto: Addiction Research Foundation, 1980)Google Scholar; Erickson, P.G. and Murray, G.F., “Cannabis Criminals Revisited,” British Journal of Addiction 81, no. 1 (1986), 77–81Google ScholarPubMed.
6. See, for example, Boyd, N., “The Origins of Canadian Narcotics Legislation.” 1984Google Scholar; Green, M., “A History of Canadian Narcotics Control: The Formative Years,” University of Toronto Faculty of Law Review 37(1979), 42–79Google Scholar; Solomon, R. and Madison, T., “The Evolution of Non-Medical Opiate Use in Canada: Part I, 1870-1929,” Drug Forum 5(1976–1977), 237–265Google Scholar.
7. House of Commons Debates, November 25, 1910 and January 26, 1911.
8. A number of sociologists have argued that one can observe and construct the natural history of a social problem since any social problem is itself a socially constructed phenomenon that evolves through predictable stages of development. See, for example, Fuller, R.C. and Myers, R.R., “The Natural History of a Social Problem,” American Sociological Review 6, no. 3 (1941), 320–329CrossRefGoogle Scholar; Kitsuse, J.I. and Spector, M., “Toward a Sociology of Social Problems: Social Conditions, Value-Judgements and Social Problems,” Social Problems 20 (1973), 407–419CrossRefGoogle Scholar; Peyrot, M., “Cycles of Social Problem Development: The Case of Drug Abuse,” The Sociological Quarterly 25 (1984), 83–95CrossRefGoogle Scholar; Reasons, C., “The Politics of Drugs: An Inquiry in the Sociology of Social Problems,” The Sociological Quarterly 15 (1974), 381–404CrossRefGoogle Scholar; Schneider, J.W., “Social Problems Theory: The Constructionist View,” Annual Review of Sociology 11 (1985), 209–229CrossRefGoogle Scholar.
9. Ashley, R., Cocaine: Its History, Uses and Effects (New York: St. Martin's Press, 1975)Google Scholar.
10. Ashley, Cocaine.
11. Musto, D.F., “A Study in Cocaine: Sherlock Holmes and Sigmund Freud,” Journal of the American Medical Association 204, no.1 (1968), 128Google ScholarPubMed.
12. Ashley, , Cocaine, 50Google Scholar.
13. Excerpt from Louisville Medical News, “Coca in the Opium Habit,” Therapeutic Gazette (1880), 215Google Scholar.
14. Ashley, , Cocaine, 55Google Scholar.
15. Phillips, J.L. and Wynne, R.D., Cocaine: The Mystique and the Reality (New York: Avon Books, 1980), 53Google Scholar.
16. Parke, Davis & Company, “Coca Erythroxylon and Its Derivatives,” (1885) in -Byck, R. (ed.), Cocaine Papers (New York: A Meridan Book, 1974), 134Google Scholar.
17. Editorial, “Cocain[e] in Canada,” Canadian Medical Association Journal 3, no. 4 (1913), 302Google Scholar.
18. Phillips, and Wynne, , Cocaine, 49Google Scholar.
19. See Anglin, L., Cocaine: A Selection of Annotated Papers from 1880 to 1984 Concerning Health Effects (Toronto: Addiction Research Foundation, 1985)Google Scholar.
20. Excerpt from Un. Med. du Canada, “Chronic Cocainism from Catarrh Snuff,” Journal of the American Medical Association 28 (1897), 1092Google Scholar.
21. Anglin, , Cocaine, ixGoogle Scholar.
22. Musto, , “A Study in Cocaine,” 130Google Scholar.
23. Ashley, , Cocaine, 1975Google Scholar.
24. Starr, P., The Social Transformation of American Medicine (New York: Basic Books, 1982), 127–128Google Scholar.
25. In 1980 there were 44,275 physicians, with a ratio of 544 persons per physician, Coburn, D., Torrance, G.M. and Kaufert, J.M., “Medical Dominance in Canada in Historical Perspective: The Rise and Fall of Medicine?” International Journal of Health Services 13, no. 3 (1983), 413CrossRefGoogle Scholar.
26. Presbrey, F., The History and Development of Advertising (New York: Greenwood Press, 1968), 291Google Scholar.
27. Census of Canada, 1880–81 Volume III (Ottawa: Maclean, Roger & Co., 1882)Google Scholar; 1890–91, 1894.
28. Editorial, “Patent Medicines,” Montreal Medical Journal 35, no. 4 (1906), 274Google Scholar.
29. Clark, R.J., “The Nether World of Professionalization: Druggists in Nineteenth-Century Ontario,” a Paper presented to the History Workshop on Education in Modern Societies, University of Waterloo, March 11-13, 1983, 7–8Google Scholar.
30. Bliss, J.W.M., “A Living Profit: Studies in the Social History of Canadian Business, 1883-1911,” Ph.D. Dissertation, Department of History, University of Toronto, 1972, 1Google Scholar.
31. Burbidge, G.A., President, Nova Scotia Pharmaceutical Association, “Patent Medicine Legislation and Canadian Pharmaceutical Association,” Canadian Pharmaceutical Journal 40(May 1907), 475Google Scholar.
32. Raison, A.V., “A Brief History of Pharmacy in Canada” (Toronto: Canadian Pharmaceutical Association, 1967), 9 (mimeo)Google Scholar.
33. Editorial, “Patent Medicines,” Montreal Medical Journal 33, no. 9 (1904), 656Google Scholar.
34. Editorial, “Cocaine Selling in Quebec,” Canadian Pharmaceutical Journal 44(December 1910), 213Google Scholar.
35. Editorial, “Drug Habits,” Canadian Pharmaceutical Journal 39 (September 1905), 67Google Scholar.
36. Editorial, “Anti-Cocaine Bill,” Canadian Pharmaceutical Journal 41 (April 1908), 401Google Scholar.
37. Editorial, “Cocaine Restriction,” Canadian Pharmaceutical Journal 41 (April 1908), 404Google Scholar.
38. Editorial, “Cocaine Selling in Quebec,” Canadian Pharmaceutical Journal 44 (December 1910), 213Google Scholar.
39. Editorial, “Cocaine Pilfering,” Canadian Pharmaceutical Journal 41 (May 1908), 456Google Scholar.
40. Editorial, “The Sale of Cocaine,” Canadian Pharmaceutical Journal 42 (November 1908), 176Google Scholar.
41. Editorial, “Illegal Cocaine Selling,” Canadian Pharmaceutical Journal 44 (February 1911), 306Google Scholar.
42. House of Commons Debates, January 26, 1911, 2523.
43. House of Commons Debates, January 26, 1911, 2523.
44. House of Commons Debates, November 25, 1910, 261.
45. House of Commons Debates, January 26, 1911, 2526.
46. House of Commons Debates, January 26, 1911, 2526.
47. House of Commons Debates, January 26, 1911, 2527-2528.
48. House of Commons Debates, January 26, 1911, 2528.
49. Cook, R., The Regenerators: Social Criticism in Late Victorian English Canada (Toronto: University of Toronto Press, 1985), 25Google Scholar.
50. Ibid., 227.
51. Ibid., 8.
52. Ibid., 227.
53. During this era there was rapid growth in the population of Canadian cities. For example, from 1891 to 1911 the two largest cities–Montreal and Toronto–more than doubled in population. The third and fourth largest cities in 1911 were Winnipeg and Vancouver. They increased more than five and eight-fold, respectively, during the same period. Brown, R.C. and Cook, R., Canada, 1896-1921: A Nation Transformed (Toronto: McClelland & Stewart, 1974), 99Google Scholar.
54. Allen, R. (ed.), “The Social Gospel in Canada,” National Museum of Man, Mercury Series, History Division, Paper No. 9, Ottawa, 1975, 13Google Scholar.
55. Rutherford, P., A Victorian Authority: The Daily Press in Late Nineteenth Century Canada (Toronto: University of Toronto Press, 1982), 171Google Scholar.
56. Rutherford, P., “Introduction,” in Rutherford, P. (ed.), Saving the Canadian City: The First Phase, 1880-1920 (Toronto: University of Toronto Press, 1974), ixGoogle Scholar.
57. Rutherford, , A Victorian Authority, 171Google Scholar.
58. Brown, R.C. and Cook, R., Canada, 1896-1921, 3Google Scholar.
59. Giffen, P.J., Small, S. and Lambert, S., “Politics of Canadian Narcotic Drug Control,” Unpublished Manuscript (Toronto: Addiction Research Foundation, 1982)Google Scholar. In comparison to the era of social reform, we have less faith in the effectiveness of legal sanctions today. Certainly, as far as non-medical drug use is concerned, it is well known that use burgeoned in the late 1960s and early 1970s in spite of the severe maximum penalties that were available in law. Also, that there are social and economic consequences associated with the “war on drugs” is common knowledge. And it is old news to learn that enforcement efforts are making only a small dent in the problem. Moreover, the public is more aware, today, of the potential of other sources of control, such as education and treatment.
60. See Giffen et al., “Politics of Canadian Narcotic Drug Control,” for a complete presentation of the paper.
61. Sessional Papers, “To an Order of the House of Commons, dated April 23, 1906, for a copy of the Report of A.E. DuBerger on the Drug and Proprietary Medicine Trade of Canada,” Sessional Papers 40(14), No. 125 (1906), 17Google Scholar.
62. For some discussion see, Guest, R.G., “The Development of Patent Medicine Legislation,” Applied Therapeutics 8 (1966), 786–789Google ScholarPubMed; Soucy, P., “The Proprietary or Patented Medicine Act of Canada,” Food Drug Cosmetic Law Journal 8 (1953), 706–716Google Scholar.
63. The development of Proprietary and Patent Medicine legislation in Canada is the topic of the author's Ph.D. thesis.
64. Phillips, J.L. and Wynne, R.D., Cocaine: The Mystique and the Reality, 53Google Scholar.
65. Sessional Papers 40 (14) (1906), No. 125, 16.
66. See, for example, Boyd, , “The Origins of Canadian Narcotics Legislation,” 102–136Google Scholar; Cook, S.J., Ideology and Canadian Narcotics Legislation, 1980-1923, M.A. Dissertation, Department of Sociology, University of Toronto, 1964Google Scholar; Giffen et al., “Politics of Canadian Narcotic Drug Control”; Green, M., “A History of Canadian Narcotics Control: The Formative Years,” 42–79Google Scholar; Solomon, R. and Madison, T., “The Evolution of Non-Medical Opiate Use in Canada: Part I, 1870-1929,” 237–265Google Scholar.
67. Giffen et al., “Politics of Canadian Narcotic Drug Control.”
68. House of Commons Debates, November 25, 1910, 259.
69. House of Commons Debates, November 25, 1910, 261.
70. House of Commons Debates, November 25, 1910, 260.
71. House of Commons Debates, January 26, 1911, 2524.
72. House of Commons Debates, January 26, 1911, 2527-2528.
73. House of Commons Debates, January 26, 1911, 2524-2525.
74. House of Commons Debates, January 26, 1911, 2525.
75. Gusfield, J.R., The Culture of Public Problems: Drinking-Driving and the Symbolic Order (Chicago: The University of Chicago Press, 1981)Google Scholar.
76. See, for example, Boyd, , “The Origins of Canadian Narcotics Legislation,” 1984Google Scholar; Green, M., “A History of Canadian Narcotics Control,” 1979Google Scholar; Solomon, R. and Madison, T., “The Evolution of Non-Medical Opiate Use in Canada,” 1976–1977Google Scholar.
77. The contrasting conclusion drawn from the present work is not novel. Giffen et al. (Politics of Canadian Narcotic Drug Control, 1982), also questioned the primacy of the minority group explanation in the development of Canadian narcotics legislation, specifically. Moreover, the present work supports parallel research in the United States (See, for example, Reasons, C., “The Politics of Drugs,” 1974Google Scholar; Starr, P., The Social Transformation of American Medicine, 1982Google Scholar; Temin, P., Taking Your Medicine: Drug Regulation in the United States (Cambridge, Mass.: Harvard University Press, 1980)CrossRefGoogle Scholar. Nevertheless, Hagan (Hagan, J., “The Legislation of Crime and Delinquency: A Review of Theory, Method, and Research,” Law and Society Review 14, no. 3 (1980), 603–628CrossRefGoogle Scholar) reached the following conclusion after reviewing the literature (all but one of the studies reviewed were done in the United States): “There is little doubt that narcotics legislation was partly an expression of hostile attitudes toward minority groups associated with drug use. … It made little difference in Canada or the United States that the ‘evidence clearly indicate[d] that the upper and middle classes predominated among narcotic addicts in the period up to 1914.’ Duster, T., The Legislation of Morality: Law, Drugs and Moral Judgement (New York: The Free Press, 1970), 9Google Scholar.
78. Temin, , Taking Your Medicine, 20Google Scholar.